Group B:R-T
Sponsors
Beijing Shijitan Hospital Capital Medical University
Conditions
GliomaMultiple myeloma
Phase 1
Bioequivalence of Temozolomide capsules to Chinese cancer patients in an open-label, randomised, single-dose, fasting, two-way crossover study
Active, not recruitingChiCTR-IPR-15006282
Start: 2015-04-28Updated: 2017-04-18
Bioequivalence of Lenalidomide capsules to healthy Chinese male volunteers in an open-label, randomised, single-dose,fasting,two-way crossover study
RecruitingChiCTR-OPR-15006279
Start: 2015-03-10Updated: 2017-04-18
Bioequivalence of Lenalidomide capsules to healthy Chinese male volunteers in an open-label, randomised, single-dose, after the meal, two-way crossover study
RecruitingChiCTR-IPR-15006280
Start: 2015-03-10Updated: 2017-04-18